Norwegian version of this page

Convergence environments I

UiO:Life Science funds convergence environments – interdisciplinary research groups that address major challenges within health and environment. 

These convergence environments were established in the autumn 2017 after an application process in 2016/2017.

The next application round starts in August 2018

  • Combining natural and social sciences to understand and manage global anthropogenic toxicants (AnthroTOX) 
    The vision of the convergence environment is to understand how environmental and social processes and their relationships dictate flows and impacts of anthropogenic toxicants from electronic waste. This will be studied within and across societies and ecosystems. Results from Tanzania will be compared to data from the Arctic. Read more.
  • Epigenetics and bioethics of human embryonic development
    The convergence environment wants to understand the epigenetic reprogramming of early embryo development and its significance for human reproduction both scientifically and ethically. An overarching theme will be the understanding of epigenetic information in the passing of life from one generation of humans to the next. Read more.
  • Programmable Cell-like Compartments
    The convergence environment will develop cell-like compartments which can in the future be assembled and programmed to track and deactivate hazards such as pathogenic microorganisms, migrating cancerous cells, plastics micro-particles, or heavy metal sediments. Read more.
  • Comparative immunology of fish and humans (COMPARE)
    The overarching goal of the convergence environment is to find out how the peculiar immune system of the codfishes function in detail and what its implications are for human immune disease. The results will affect future aquaculture, human medicine as well as providing a social sciences case for our awareness of the future possibilities of gene modifications of fish and humans. Read more.
  • Organ on a chip and nano-devices (CHIP)
    The convergence environment will develop an “Organ on a chip” interface. This will provide a powerful new platform for understanding and testing of physiological functions and therapeutic interventions. Read more.
  • Personalised cancer therapies (PERCATHE)
    The convergence environment will develop a new approach to personalised cancer therapy, based on mathematical, statistical and biological methods. It will also study the ethical, societal and regulatory perspectives. Read more
  • The genetic history of Eastern Eurasia (ARCH-GEN)The convergence environment will unveil the patterns and processes that have shaped the cultural and genetic landscape of human populations in Eastern Eurasia using a wide range of multidisciplinary tools and approaches.
    Due to unforeseen circumstances, the projects could not be performed as planned. Therefore, the UiO:Life Science board decided to withdrawn the support in November 2018.
Published May 2, 2017 3:34 PM - Last modified Nov. 21, 2018 1:45 PM